Active Ingredient History
Benralizumab, sold under the brand name Fasenra, is a monoclonal antibody directed against the alpha chain of the interleukin-5 receptor (CD125). It was developed by MedImmune for the treatment of asthma. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Anti-Asthmatic Agents (Phase 2)
Aspergillosis (Phase 4)
Aspergillosis, Allergic Bronchopulmonary (Phase 4)
Asthma ()
Asthma, Exercise-Induced (Phase 3)
Breast Neoplasms (Phase 2)
Chronic Urticaria (Phase 4)
Churg-Strauss Syndrome (Phase 3)
Cystic Fibrosis (Phase 3)
Dermatitis (Phase 2)
Dermatitis, Atopic (Phase 2)
Eczema (Phase 2)
Eosinophilia (Phase 2)
Eosinophilic Esophagitis (Phase 3)
Eosinophils (Phase 2)
Gastritis (Phase 3)
Gastroenteritis (Phase 3)
Genetic Diseases, Inborn (Phase 2)
Healthy Volunteers (Phase 1)
Hematologic Diseases (Phase 2)
Hematologic Neoplasms (Phase 2)
Hypereosinophilic Syndrome (Phase 3)
Hypersensitivity (Phase 2)
Hypersensitivity, Immediate (Phase 2)
Immune System Diseases (Phase 2)
Leukocyte Disorders (Phase 2)
Nasal Polyps (Phase 3)
Neoplasms (Phase 2)
Pemphigoid, Bullous (Phase 3)
Prurigo (Phase 2)
Pulmonary Disease, Chronic Obstructive (Phase 3)
Respiratory System Agents (Phase 2)
Sinusitis (Phase 2)
Skin Diseases (Phase 2)
Skin Diseases, Eczematous (Phase 2)
Skin Diseases, Genetic (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
